chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Headache, Paraesthesia, Product dose omission issue
Clinical narrative: Felt tingling in arms; Pain from middle of back, up to neck; Felt like head was being squeezed, I never had a headache like that in my life.; having trouble eating; Patient expressed frustration; Fatigue; The patient did not receive their second dose; Headache worsened by second day, I couldn't lay my head down/Pounding Headache/wrapped around head; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Felt tingling in arms), BACK PAIN (Pain from middle of back, up to neck), HEAD DISCOMFORT (Felt like head was being squeezed, I never had a headache like that in my life.), FEEDING DISORDER (having trouble eating) and FRUSTRATION TOLERANCE DECREASED (Patient expressed frustration) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Patient medical history was not provided.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Felt tingling in arms), BACK PAIN (Pain from middle of back, up to neck), HEAD DISCOMFORT (Felt like head was being squeezed, I never had a headache like that in my life.), FEEDING DISORDER (having trouble eating), FRUSTRATION TOLERANCE DECREASED (Patient expressed frustration), FATIGUE (Fatigue), HEADACHE (Headache worsened by second day, I couldn't lay my head down/Pounding Headache/wrapped around head) and PRODUCT DOSE OMISSION ISSUE (The patient did not receive their second dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Felt tingling in arms), BACK PAIN (Pain from middle of back, up to neck), HEAD DISCOMFORT (Felt like head was being squeezed, I never had a headache like that in my life.), FEEDING DISORDER (having trouble eating), FRUSTRATION TOLERANCE DECREASED (Patient expressed frustration) and FATIGUE (Fatigue) outcome was unknown and HEADACHE (Headache worsened by second day, I couldn't lay my head down/Pounding Headache/wrapped around head) and PRODUCT DOSE OMISSION ISSUE (The patient did not receive their second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypoaesthesia, Paraesthesia, Vaccination site pain
Clinical narrative: tingling; numbness in arms which resolved on it's own; Left arm injection site pain; Slight headache; I felt pretty tired after both doses; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling), HYPOAESTHESIA (numbness in arms which resolved on it's own), VACCINATION SITE PAIN (Left arm injection site pain), HEADACHE (Slight headache) and FATIGUE (I felt pretty tired after both doses) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included TRAZODONE, OMEPRAZOLE, BISOPROLOL, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), ASPIRIN [ACETYLSALICYLIC ACID], SERTRALINE HYDROCHLORIDE (ZOLOFT), VITAMIN B COMPLEX (B COMPLEX [VITAMIN B COMPLEX]) and UBIDECARENONE (COQ10 [UBIDECARENONE]) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PARAESTHESIA (tingling), HYPOAESTHESIA (numbness in arms which resolved on it's own), VACCINATION SITE PAIN (Left arm injection site pain), HEADACHE (Slight headache) and FATIGUE (I felt pretty tired after both doses). In 2021, PARAESTHESIA (tingling) and HYPOAESTHESIA (numbness in arms which resolved on it's own) had resolved. At the time of the report, VACCINATION SITE PAIN (Left arm injection site pain) and HEADACHE (Slight headache) had not resolved and FATIGUE (I felt pretty tired after both doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-344194 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Dyspnoea, Fatigue, Hypoaesthesia
Clinical narrative: still feels a little bit hard to breathe; slight heaviness in my chest; numbness in my knuckle; can feel aching pain and numbness in my knuckle; joints were so stiff; about 45 minutes to an hour later, chest started tightening up/ felt like lungs were turning to concrete/ sensation of hardening; right hand joints were swollen; painful fingers; totally exhausted; injection site was very very hard on my right arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (about 45 minutes to an hour later, chest started tightening up/ felt like lungs were turning to concrete/ sensation of hardening), JOINT SWELLING (right hand joints were swollen), JOINT STIFFNESS (joints were so stiff), DYSPNOEA (still feels a little bit hard to breathe) and CHEST DISCOMFORT (slight heaviness in my chest) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arteriosclerosis.    On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Oct-2021, the patient experienced CHEST DISCOMFORT (about 45 minutes to an hour later, chest started tightening up/ felt like lungs were turning to concrete/ sensation of hardening), JOINT SWELLING (right hand joints were swollen), PAIN IN EXTREMITY (painful fingers), FATIGUE (totally exhausted) and INJECTION SITE INDURATION (injection site was very very hard on my right arm). On 05-Oct-2021, the patient experienced JOINT STIFFNESS (joints were so stiff). On 06-Oct-2021, the patient experienced DYSPNOEA (still feels a little bit hard to breathe), CHEST DISCOMFORT (slight heaviness in my chest), HYPOAESTHESIA (numbness in my knuckle) and ARTHRALGIA (can feel aching pain and numbness in my knuckle). At the time of the report, CHEST DISCOMFORT (about 45 minutes to an hour later, chest started tightening up/ felt like lungs were turning to concrete/ sensation of hardening), JOINT SWELLING (right hand joints were swollen), JOINT STIFFNESS (joints were so stiff), DYSPNOEA (still feels a little bit hard to breathe), CHEST DISCOMFORT (slight heaviness in my chest), HYPOAESTHESIA (numbness in my knuckle), PAIN IN EXTREMITY (painful fingers), FATIGUE (totally exhausted), INJECTION SITE INDURATION (injection site was very very hard on my right arm) and ARTHRALGIA (can feel aching pain and numbness in my knuckle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Cardiac Lab values (ECG, cardiac test, cardiac enzymes): none No history of myocarditis or pericardtis  No concomitant medications reported. No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Joint stiffness, Joint swelling, Pain in extremity
Clinical narrative: still feels a little bit hard to breathe; slight heaviness in my chest; numbness in my knuckle; can feel aching pain and numbness in my knuckle; joints were so stiff; about 45 minutes to an hour later, chest started tightening up/ felt like lungs were turning to concrete/ sensation of hardening; right hand joints were swollen; painful fingers; totally exhausted; injection site was very very hard on my right arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (about 45 minutes to an hour later, chest started tightening up/ felt like lungs were turning to concrete/ sensation of hardening), JOINT SWELLING (right hand joints were swollen), JOINT STIFFNESS (joints were so stiff), DYSPNOEA (still feels a little bit hard to breathe) and CHEST DISCOMFORT (slight heaviness in my chest) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arteriosclerosis.    On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Oct-2021, the patient experienced CHEST DISCOMFORT (about 45 minutes to an hour later, chest started tightening up/ felt like lungs were turning to concrete/ sensation of hardening), JOINT SWELLING (right hand joints were swollen), PAIN IN EXTREMITY (painful fingers), FATIGUE (totally exhausted) and INJECTION SITE INDURATION (injection site was very very hard on my right arm). On 05-Oct-2021, the patient experienced JOINT STIFFNESS (joints were so stiff). On 06-Oct-2021, the patient experienced DYSPNOEA (still feels a little bit hard to breathe), CHEST DISCOMFORT (slight heaviness in my chest), HYPOAESTHESIA (numbness in my knuckle) and ARTHRALGIA (can feel aching pain and numbness in my knuckle). At the time of the report, CHEST DISCOMFORT (about 45 minutes to an hour later, chest started tightening up/ felt like lungs were turning to concrete/ sensation of hardening), JOINT SWELLING (right hand joints were swollen), JOINT STIFFNESS (joints were so stiff), DYSPNOEA (still feels a little bit hard to breathe), CHEST DISCOMFORT (slight heaviness in my chest), HYPOAESTHESIA (numbness in my knuckle), PAIN IN EXTREMITY (painful fingers), FATIGUE (totally exhausted), INJECTION SITE INDURATION (injection site was very very hard on my right arm) and ARTHRALGIA (can feel aching pain and numbness in my knuckle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Cardiac Lab values (ECG, cardiac test, cardiac enzymes): none No history of myocarditis or pericardtis  No concomitant medications reported. No treatment information was provided.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: My son had body aches; My son had fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (My son had body aches) and PYREXIA (My son had fever) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Oct-2021, the patient experienced MYALGIA (My son had body aches) and PYREXIA (My son had fever). At the time of the report, MYALGIA (My son had body aches) and PYREXIA (My son had fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   NO Concomitant medication was reported No treatment Drug was reported   This case was linked to MOD-2021-344209 (Patient Link).
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: He had body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (He had body aches) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced MYALGIA (He had body aches). At the time of the report, MYALGIA (He had body aches) outcome was unknown.            No concomitant medications were not reported. No treatment medications were not provided.   This case was linked to MOD-2021-344206 (Patient Link).
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Numbness on the left side of face; Tongue is numb; This spontaneous case was reported by a nurse and describes the occurrence of HYPOAESTHESIA (Numbness on the left side of face) and HYPOAESTHESIA ORAL (Tongue is numb) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Oct-2021, the patient experienced HYPOAESTHESIA (Numbness on the left side of face) and HYPOAESTHESIA ORAL (Tongue is numb). At the time of the report, HYPOAESTHESIA (Numbness on the left side of face) and HYPOAESTHESIA ORAL (Tongue is numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment medications were not provided by reporter.  The patient stated that five days after the shot, showed up in clinic complaining that the left side of his face was numb and his tongue was numb.  The patient did not have difficulty breathing and performing tests.  patient does not have a family history of Bell's Palsy.; Sender's Comments: This case concerns a 51-year-old male patient with no relevant medical history, who experienced the unexpected events of Hypoesthesia and Hypoesthesia Oral. The events occurred 5 days after the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). The rechallenge was not applicable since only information about the first dose was disclosed. The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: administered with the vaccine at 15 years old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 15 years old) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 15 years old). On 28-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 15 years old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine headache). At the time of the report, MIGRAINE (Migraine headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported. No treatment Drug was reported.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Painful left arm for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful left arm for 24 hours) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     Concurrent medical conditions included Herpes simplex type I. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for Herpes simplex type I.    On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, the patient experienced PAIN IN EXTREMITY (Painful left arm for 24 hours). On 27-Aug-2021, PAIN IN EXTREMITY (Painful left arm for 24 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.    This case was linked to MOD-2021-344229 (Patient Link).
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after improper storage & handling; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Oct-2021 and was forwarded to Moderna on 06-Oct-2021.    This spontaneous case was reported by a medical assistant and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered after improper storage & handling) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered after improper storage & handling). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered after improper storage & handling) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided  No treatment medications were provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Had a 100 degrees F fever ongoing until today/in the morning he will have a fever of 99.1 ranging to 101 degrees F by evening; Chills when traveling on the plane; Felt achy; Fever of 103 degrees F for about a day and a half total of 24-36 hour; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Had a 100 degrees F fever ongoing until today/in the morning he will have a fever of 99.1 ranging to 101 degrees F by evening), CHILLS (Chills when traveling on the plane), MYALGIA (Felt achy) and PYREXIA (Fever of 103 degrees F for about a day and a half total of 24-36 hour) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A and 939902) for COVID-19 vaccination.     Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for HSV infection.   On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, the patient experienced MYALGIA (Felt achy) and PYREXIA (Fever of 103 degrees F for about a day and a half total of 24-36 hour). On 01-Oct-2021, the patient experienced PYREXIA (Had a 100 degrees F fever ongoing until today/in the morning he will have a fever of 99.1 ranging to 101 degrees F by evening) and CHILLS (Chills when traveling on the plane). The patient was treated with PARACETAMOL, PHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE (THERAFLU [PARACETAMOL;PHENIRAMINE MALEATE;PHENYLEPHRINE HYDROCHLORIDE]) for Adverse reaction, at a dose of 1 dosage form. On 25-Sep-2021, MYALGIA (Felt achy) and PYREXIA (Fever of 103 degrees F for about a day and a half total of 24-36 hour) had resolved. At the time of the report, PYREXIA (Had a 100 degrees F fever ongoing until today/in the morning he will have a fever of 99.1 ranging to 101 degrees F by evening) had not resolved and CHILLS (Chills when traveling on the plane) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Sep-2021, Body temperature: 103 (High) 103 degrees F. On 01-Oct-2021, Body temperature: 100 (High) 100 degrees F. On 02-Oct-2021, SARS-CoV-2 test: negative (Negative) Negative. On an unknown date, Body temperature: 99.1 to 101 (High) Fever of 99.1 ranging to 101 degrees F.         This case was linked to MOD-2021-344216 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, SARS-CoV-2 test, Vaccination site swelling
Clinical narrative: SWELLING OF INJECTION SITE; received the expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE SWELLING (SWELLING OF INJECTION SITE) and EXPIRED PRODUCT ADMINISTERED (received the expired vaccine) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in August 2021.   On 28-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received the expired vaccine). On 29-Sep-2021, the patient experienced VACCINATION SITE SWELLING (SWELLING OF INJECTION SITE). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (received the expired vaccine) had resolved. On 01-Oct-2021, VACCINATION SITE SWELLING (SWELLING OF INJECTION SITE) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. No treatment medication reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2021: Added medical history information. Added lab data information. Added Route and anatomical location of vaccine administration. Added event.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dyskinesia, Extrapyramidal disorder, Gait inability, Hypersomnia, Illness
Clinical narrative: extrapyramidal symptoms; body started jerking; couldn't walk; legs buckled; sick for two days from the second vaccination/woke up and felt so ill; slept the whole day; bad reactions/scary reactions; vomited like mad; This spontaneous case was reported by a consumer and describes the occurrence of EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled) and ILLNESS (sick for two days from the second vaccination/woke up and felt so ill) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (The patient put off having the vaccination because they felt they had antibodies.) in January 2021 and Hip surgery (bad back). Concomitant products included PARACETAMOL (TYLENOL), GABAPENTIN, TRAMADOL, IRON, OLMESARTAN, ATORVASTATIN, LORATADINE and MONTELUKAST for an unknown indication.    On 09-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled), ILLNESS (sick for two days from the second vaccination/woke up and felt so ill), HYPERSOMNIA (slept the whole day), VACCINATION COMPLICATION (bad reactions/scary reactions) and VOMITING (vomited like mad). The patient was treated with ONDANSETRON for Vomiting, at a dose of 1 dosage form. On 09-Sep-2021, VOMITING (vomited like mad) had resolved. At the time of the report, EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled), ILLNESS (sick for two days from the second vaccination/woke up and felt so ill), HYPERSOMNIA (slept the whole day) and VACCINATION COMPLICATION (bad reactions/scary reactions) outcome was unknown.            The patient was visiting her children at the moment and expresses her concerns about future travel requiring the booster dose. She wanted to know what to do if she wanted to travel but doesn't want to take the third booster dose. She said they wont let her travel without taking it. She asked if she should take the third booster dose.   This case was linked to MOD-2021-344049 (Patient Link).; Sender's Comments: This case concerns a 71-year-old female patient with no relevant medical history, who experienced the unexpected event of hypersomnia. The event occurred on the same day after the second dose of mRNA-1273 (Moderna COVID-19 Vaccine). The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination complication, Vomiting
Clinical narrative: extrapyramidal symptoms; body started jerking; couldn't walk; legs buckled; sick for two days from the second vaccination/woke up and felt so ill; slept the whole day; bad reactions/scary reactions; vomited like mad; This spontaneous case was reported by a consumer and describes the occurrence of EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled) and ILLNESS (sick for two days from the second vaccination/woke up and felt so ill) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (The patient put off having the vaccination because they felt they had antibodies.) in January 2021 and Hip surgery (bad back). Concomitant products included PARACETAMOL (TYLENOL), GABAPENTIN, TRAMADOL, IRON, OLMESARTAN, ATORVASTATIN, LORATADINE and MONTELUKAST for an unknown indication.    On 09-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled), ILLNESS (sick for two days from the second vaccination/woke up and felt so ill), HYPERSOMNIA (slept the whole day), VACCINATION COMPLICATION (bad reactions/scary reactions) and VOMITING (vomited like mad). The patient was treated with ONDANSETRON for Vomiting, at a dose of 1 dosage form. On 09-Sep-2021, VOMITING (vomited like mad) had resolved. At the time of the report, EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled), ILLNESS (sick for two days from the second vaccination/woke up and felt so ill), HYPERSOMNIA (slept the whole day) and VACCINATION COMPLICATION (bad reactions/scary reactions) outcome was unknown.            The patient was visiting her children at the moment and expresses her concerns about future travel requiring the booster dose. She wanted to know what to do if she wanted to travel but doesn't want to take the third booster dose. She said they wont let her travel without taking it. She asked if she should take the third booster dose.   This case was linked to MOD-2021-344049 (Patient Link).; Sender's Comments: This case concerns a 71-year-old female patient with no relevant medical history, who experienced the unexpected event of hypersomnia. The event occurred on the same day after the second dose of mRNA-1273 (Moderna COVID-19 Vaccine). The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Metallic objects (keys, scissors) that are clinging to body post vaccination/ sticking on shoulder, chest, forhead and cheeks; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Metallic objects (keys, scissors) that are clinging to body post vaccination/ sticking on shoulder, chest, forhead and cheeks) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Oct-2021, the patient experienced VACCINATION COMPLICATION (Metallic objects (keys, scissors) that are clinging to body post vaccination/ sticking on shoulder, chest, forhead and cheeks). At the time of the report, VACCINATION COMPLICATION (Metallic objects (keys, scissors) that are clinging to body post vaccination/ sticking on shoulder, chest, forhead and cheeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  The reached out to the pharmacist who gave the vaccine and showed them the event.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Liver transplant. Concurrent medical conditions included Immunocompromised (immunocompromised patient).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   HCP reports patient received Pfizer Covid-19 Vaccine as third dose in her pharmacy on 6 Oct 2021 as patient was immunocompromised.  No concomitant medications was reported. No treatment drug details was reported.   This case was linked to MOD-2021-344241 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.   No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Liver transplant. Concurrent medical conditions included Immunocompromised.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received Pfizer COVID-19 Vaccine as third dose on 6 Oct 2021.  Concomitant medication of the patient was not reported. No treatment information was provided by the reporter.   This case was linked to MOD-2021-344235 (Patient Link).
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: administered with the vaccine at 13 years old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 13 years old) in a 13-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 13 years old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 13 years old) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported. No concomitant treatment was reported.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received the expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received the expired vaccine) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included METOPROLOL SUCCINATE for an unknown indication.    On 24-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received the expired vaccine). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Received the expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2021: Follow up  received on 8 Oct 2021 , Medical history, Vaccine facility information added and patient race, ethnicity, patient route of administration and anatomical location  updated, current condition added. Concomitant medication added.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received the expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     Concurrent medical conditions included Immune system disorder (Weakened immune system from premature birth) since 18-Feb-2001.    On 24-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes on 08-Oct-2021 Follow up received and contains patient demographics, medical history, and product details, batch number updated.
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Not immunocompromised received a third dose of the Moderna covid 19 vaccine,; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Not immunocompromised received a third dose of the Moderna covid 19 vaccine,) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (Not immunocompromised received a third dose of the Moderna covid 19 vaccine,). At the time of the report, EXTRA DOSE ADMINISTERED (Not immunocompromised received a third dose of the Moderna covid 19 vaccine,) had resolved.            No concomitant medications was reported. No treatment drug details was reported.  Patient was not immunocompromised.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Nasopharyngitis, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), NASOPHARYNGITIS (Feels like a cold) and PYREXIA (Had a little temperature) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 013L20) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer, Chronic respiratory disease, Wheezy bronchitis and Knee pain. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (WIXELA INHUB) from June 2021 to an unknown date for Chronic respiratory disease, ALBUTEROL SULFATE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN, POTASSIUM CHLORIDE, ASPIRIN [ACETYLSALICYLIC ACID], VITAMIN D [VITAMIN D NOS], DOCUSATE SODIUM (COLACE), LEVOTHYROXINE, MELOXICAM, VARICELLA ZOSTER VACCINE, LORATADINE, OMEPRAZOLE and MACROGOL 3350 (MIRALAX) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Oct-2021, the patient experienced DYSPNOEA (Difficulty breathing) and NASOPHARYNGITIS (Feels like a cold). On an unknown date, the patient experienced PYREXIA (Had a little temperature). At the time of the report, DYSPNOEA (Difficulty breathing), NASOPHARYNGITIS (Feels like a cold) and PYREXIA (Had a little temperature) outcome was unknown.            As concomitant medication the patient is using eye drops as needed and water pill. For chronic respiratory condition the patient was taking medicine.   The patient mentioned that they were experiencing difficulty breathing after being at a wedding with a lot of people and air conditioning.  No treatment information was provided by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received the expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received the expired vaccine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included METOPROLOL SUCCINATE and HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HYDROCHLOROTHIAZIDE) for Hypertension.    On 24-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received the expired vaccine). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (received the expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. No treatment information was provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2021: Additional information received included route of administration, anatomical location, and concomitant drug.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Vaccination site erythema, Vaccination site swelling
Clinical narrative: RED AT INJECTION SITE (NO PAIN); SWELLING AT INJECTION SITE (NO PAIN); Patient received expired dose of the Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine), VACCINATION SITE ERYTHEMA (RED AT INJECTION SITE (NO PAIN)) and VACCINATION SITE SWELLING (SWELLING AT INJECTION SITE (NO PAIN)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Hypertension.    On 28-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine). On 29-Sep-2021, the patient experienced VACCINATION SITE ERYTHEMA (RED AT INJECTION SITE (NO PAIN)) and VACCINATION SITE SWELLING (SWELLING AT INJECTION SITE (NO PAIN)). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine) had resolved. On 02-Oct-2021, VACCINATION SITE ERYTHEMA (RED AT INJECTION SITE (NO PAIN)) and VACCINATION SITE SWELLING (SWELLING AT INJECTION SITE (NO PAIN)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2021: Follow up received and added medical history of the patient. added new events and batch number updated.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: With lots of adverse reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (With lots of adverse reactions) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (With lots of adverse reactions). At the time of the report, VACCINATION COMPLICATION (With lots of adverse reactions) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  The patient was a PSW (Personal Support Workers) at nursing home. The patient was administered with Moderna COVID vaccine last January to February 2 doses.   This case was linked to MOD-2021-344288 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received the expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received the expired vaccine) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received the expired vaccine). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (received the expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications are provided. treatment to the events not reported. patients received the expired vaccine. 21 patients received expired vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2021: Significant Follow up received- ADR form received, patient DOB updating, batch number updating.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal distension, Gastrooesophageal reflux disease, Nausea
Clinical narrative: Bloating tummy; Reflux; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISTENSION (Bloating tummy), GASTROOESOPHAGEAL REFLUX DISEASE (Reflux) and NAUSEA (Nausea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISTENSION (Bloating tummy), GASTROOESOPHAGEAL REFLUX DISEASE (Reflux) and NAUSEA (Nausea). The patient was treated with ESOMEPRAZOLE for Adverse reaction, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISTENSION (Bloating tummy), GASTROOESOPHAGEAL REFLUX DISEASE (Reflux) and NAUSEA (Nausea) outcome was unknown.            Patient consume only natural sugars (found in fruits etc) and  on a low sodium diet. No concomitant medication was provided.   This case was linked to MOD-2021-344140 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: With lots of adverse reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (With lots of adverse reactions) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (With lots of adverse reactions). At the time of the report, VACCINATION COMPLICATION (With lots of adverse reactions) outcome was unknown.            No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-344276 (Patient Link).